PL3256119T3 - Związki i kompozycje zwiększające moc wyjściową i wydajność tlenową - Google Patents
Związki i kompozycje zwiększające moc wyjściową i wydajność tlenowąInfo
- Publication number
- PL3256119T3 PL3256119T3 PL16705082.2T PL16705082T PL3256119T3 PL 3256119 T3 PL3256119 T3 PL 3256119T3 PL 16705082 T PL16705082 T PL 16705082T PL 3256119 T3 PL3256119 T3 PL 3256119T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- compounds
- power output
- improving power
- oxygen efficiency
- Prior art date
Links
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229910052760 oxygen Inorganic materials 0.000 title 1
- 239000001301 oxygen Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15154689 | 2015-02-11 | ||
| EP15190026 | 2015-10-15 | ||
| PCT/EP2016/052890 WO2016128503A1 (en) | 2015-02-11 | 2016-02-11 | Compounds and compositions for improving power output and oxygen efficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3256119T3 true PL3256119T3 (pl) | 2024-04-08 |
Family
ID=55398269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16705082.2T PL3256119T3 (pl) | 2015-02-11 | 2016-02-11 | Związki i kompozycje zwiększające moc wyjściową i wydajność tlenową |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11304967B2 (pl) |
| EP (2) | EP4257204A3 (pl) |
| AU (1) | AU2016217912A1 (pl) |
| CA (1) | CA2975195A1 (pl) |
| ES (1) | ES2966912T3 (pl) |
| PL (1) | PL3256119T3 (pl) |
| WO (1) | WO2016128503A1 (pl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6528042B1 (en) * | 1999-10-08 | 2003-03-04 | Galileo Laboratories, Inc. | Compositions of flavonoids for use as cytoprotectants and methods of making and using them |
| AU2002352726A1 (en) * | 2001-11-15 | 2003-06-10 | Galileo Laboratories, Inc. | Formulations and methods for treatment or amelioration of inflammatory conditions |
| US20040126461A1 (en) * | 2002-10-23 | 2004-07-01 | Lines Thomas Christian | Composition for enhancing physical performance |
| CA2567963A1 (en) * | 2004-05-26 | 2005-12-08 | Kgk Synergize Inc. | Functional foods comprising flavonoids and tocotrienols and methods thereof |
| US20070042972A1 (en) | 2005-05-24 | 2007-02-22 | Mckeever Kenneth H | Compositions and methods for optimizing exercise recovery |
| JP2008074838A (ja) * | 2006-08-21 | 2008-04-03 | Daiichi Sankyo Healthcare Co Ltd | グルコシルヘスペリジン含有組成物 |
| MX2007011002A (es) * | 2007-09-07 | 2009-03-09 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica. |
| EP2241313A1 (en) * | 2009-03-31 | 2010-10-20 | Nestec S.A. | Use of flavonoids to increase the bioavailability of hesperetin |
| WO2013144267A2 (en) * | 2012-03-29 | 2013-10-03 | Nestec S.A. | Improvement of musculoskeletal health by nutrition and exercise |
-
2016
- 2016-02-11 PL PL16705082.2T patent/PL3256119T3/pl unknown
- 2016-02-11 US US15/548,369 patent/US11304967B2/en active Active
- 2016-02-11 AU AU2016217912A patent/AU2016217912A1/en not_active Abandoned
- 2016-02-11 CA CA2975195A patent/CA2975195A1/en not_active Abandoned
- 2016-02-11 WO PCT/EP2016/052890 patent/WO2016128503A1/en active Application Filing
- 2016-02-11 ES ES16705082T patent/ES2966912T3/es active Active
- 2016-02-11 EP EP23189724.0A patent/EP4257204A3/en active Pending
- 2016-02-11 EP EP16705082.2A patent/EP3256119B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016128503A1 (en) | 2016-08-18 |
| US20180028546A1 (en) | 2018-02-01 |
| EP3256119B1 (en) | 2023-10-25 |
| CA2975195A1 (en) | 2016-08-18 |
| EP3256119A1 (en) | 2017-12-20 |
| ES2966912T3 (es) | 2024-04-25 |
| EP4257204A3 (en) | 2023-11-29 |
| AU2016217912A1 (en) | 2017-09-28 |
| US11304967B2 (en) | 2022-04-19 |
| EP4257204A2 (en) | 2023-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252970B (en) | Compositions and methods for genome editing in the living body with high efficiency | |
| GB2528894B (en) | Power factor correction stages in power conversion | |
| GB2541036B (en) | Power optimisation | |
| EP3267568A4 (en) | Power converter | |
| PL3295552T3 (pl) | Konwerter mocy | |
| SG11201606353TA (en) | Monolithic multijunction power converter | |
| HK1246514A1 (zh) | 具有減小尺寸的多爾蒂功率放大器 | |
| DK3309949T3 (da) | Effektomformningsindretning | |
| ZA201607507B (en) | Four-quadrant partial power processing switched-mode converter for photovoltaic applications | |
| EP3363110A4 (en) | POWER CONVERTER | |
| GB201511223D0 (en) | Power converter sub-module | |
| GB201618283D0 (en) | Power generation | |
| EP3288143A4 (en) | Ship having improved power efficiency | |
| TWI560987B (en) | Direct current power converter | |
| ZA201705848B (en) | Improvement of efficiency in power plants | |
| GB201403357D0 (en) | Power conversion | |
| GB201520961D0 (en) | Power converter | |
| GB201608305D0 (en) | Power plant | |
| GB201608304D0 (en) | Power plant | |
| GB2529018B (en) | Power converter | |
| GB201521335D0 (en) | Improvements in or relating to power semiconductor modules | |
| GB201415065D0 (en) | Inductor structure for high efficiency power conversion | |
| PL3537921T3 (pl) | Zespół zasilający | |
| PL3256119T3 (pl) | Związki i kompozycje zwiększające moc wyjściową i wydajność tlenową | |
| HK1243241A1 (zh) | 功率轉換技術 |